Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Race To Cure Multiple Sclerosis
Seeking Alpha
Thursday, July 5, 2012 - 1:12pm
tags:
MS, multiple sclerosis, Biogen Idec, Elan, Novartis, Pfizer, Sanofi, Teva Pharmaceuticals, Bayer
Bristol-Myers Squibb: Buy Before Eliquis Entry In 2013
Seeking Alpha
Thursday, July 5, 2012 - 12:56pm
tags:
Bristol-Myers Squibb, Eliquis, JNJ, Mylan, Pfizer, Dr Reddy's
Sanofi to cut 1,000-2,000 jobs in France
Reuters
Thursday, July 5, 2012 - 12:52pm
tags:
France, layoffs, Sanofi
Merck KGaA Says Erbitux Fails In Stomach Cancer Trial
Bloomberg
Thursday, July 5, 2012 - 12:51pm
tags:
Erbitux, stomach cancer, Merck KGaA
Checking the Quality of Exelixis' Growth
Motley Fool
Tuesday, July 3, 2012 - 1:08pm
tags:
Exelixis
Is Abbott Labs' Run Higher About to End?
Motley Fool
Tuesday, July 3, 2012 - 1:08pm
tags:
Abbott Laboratories
Expert On The Amylin Purchase: 'I Hate This Deal'
Forbes
Tuesday, July 3, 2012 - 1:07pm
tags:
Amylin, Bristol-Myers Squibb, M&A, AstraZeneca
Mylan selling generic version of the allergy drug Clarinex and bipolar disorder drug Lithobid
Yahoo/AP
Tuesday, July 3, 2012 - 12:21pm
tags:
generics, Clarinex, bipolar disorder, Mylan, Lithobid
Abbott gets FDA approval for cataract surgery gel
Yahoo/AP
Tuesday, July 3, 2012 - 12:21pm
tags:
FDA, cataracts, Abbott Laboratories, Healon EndoCoat
Melanoma Treatments Look To Benefit From Large Market
Seeking Alpha
Tuesday, July 3, 2012 - 11:46am
tags:
Amgen, Bristol-Myers Squibb, GSK, OncoSec, Vical
Chelsea Therapeutics shares sink after FDA recommends additional study for drug candidate
Yahoo/AP
Tuesday, July 3, 2012 - 11:45am
tags:
FDA, Northera, Chelsea Therapeutics
Pluristem Pioneering Intramuscular Placenta-Based Cell Therapies
Seeking Alpha
Tuesday, July 3, 2012 - 11:44am
tags:
Pluristem
Vivus, Onyx, Amarin Await Key Dates in July
Minyanville
Tuesday, July 3, 2012 - 11:43am
tags:
Amarin, ONYX Pharmaceuticals, Vivus, Qnexa, AMR101, Arcalyst, Regeneron, Kyprolis, Salix, Relistor, Progenics Pharmaceuticals, Rayos, Roche, Lucentis, Horizon Pharma
Today's Bio Pharma Buyout News And Watch List
Seeking Alpha
Tuesday, July 3, 2012 - 11:38am
tags:
Amylin, AstraZeneca, Obagi Medical Products, Eli Lilly, GSK, Bristol-Myers Squibb
Top Ampio Pharma execs extend lock-up agreement
Yahoo/AP
Tuesday, July 3, 2012 - 9:55am
tags:
Ampio
4 Healthcare Stocks Fueling Growth On Strong Profitability
Seeking Alpha
Tuesday, July 3, 2012 - 9:54am
tags:
Elan, Forest Labs, Pozen, Progenics Pharmaceuticals
Why Isis is facing a downside strategy
Yahoo/optionMONSTER
Tuesday, July 3, 2012 - 9:51am
tags:
Isis Pharmaceuticals
Icahn steps up attack on Forest Labs
Reuters
Tuesday, July 3, 2012 - 9:50am
tags:
Forest Labs, Carl Icahn
Believe It Or Not, Pfizer, Novartis And Other Pharma Stocks Are Still Undervalued
Forbes
Monday, July 2, 2012 - 1:19pm
tags:
Pfizer, Novartis
Ablynx trial data sweetens partnering prospects
Reuters
Monday, July 2, 2012 - 1:17pm
tags:
Ablynx, ATN-103, rheumatoid arthritis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.